TITLE

Clinical pharmacology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS9
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Verapamil metabolites--Potential P-glycoprotein-mediated multidrug resistance reversal agents,' by C. Woodland, I. Wainer et al from the McGill University.
ACCESSION #
9708235725

 

Related Articles

  • P-Glycoprotein, but not Multidrug Resistance Protein 4, Plays a Role in the Systemic Clearance of Irinotecan and SN-38 in Mice. Tagen, Michael; Yanli Zhuang; Fan Zhang; Harstead, K. Elaine; Jun Shen; Schaiquevich, Paula; Fraga, Charles H.; Panetta, John C.; Waters, Christopher M.; Stewart, Clinton F. // Drug Metabolism Letters;Dec2010, Vol. 4 Issue 4, p195 

    The ATP-binding cassette transporters P-glycoprotein (ABCB1, MDR1) and multidrug resistance protein 4 (MRP4) efflux irinotecan and its active metabolite SN-38 in vitro, and thus may contribute to system clearance of these compounds. Mdr1a/b-/-, Mrp4-/-, and wild-type mice were administered 20 or...

  • HZ08 Reverse P-Glycoprotein Mediated Multidrug Resistance In Vitro and In Vivo. Hu, Zheyi; Zhou, Zaigang; Hu, Yahui; Wu, Jinhui; Li, Yunman; Huang, Wenlong // PLoS ONE;Feb2015, Vol. 10 Issue 2, p1 

    Background: Multidrug efflux transporter P-glycoprotein (P-gp) is highly expressed on membrane of tumor cells and is implicated in resistance to tumor chemotherapy. HZ08 is synthesized and studied in order to find a novel P-gp inhibitor. Methods: MDCK-MDR1 monolayer transport, calcein-AM P-gp...

  • As Easy as ABC: Scientists Fish Out Another Drug Resistance Gene. Kuska, Bob // JNCI: Journal of the National Cancer Institute;03/03/99, Vol. 91 Issue 5, p402 

    Reports that scientists have identified several P-glycoprotein genes involved in chemoresistance. Background information on the ABC transporter genes; Explanations from the scientists; Lessons learned by the scientists.

  • Metabolism of (R)-[11C]verapamil in epilepsy patients. Abrahim, Aiman; Luurtsema, Gert; Bauer, Martin; Karch, Rudolf; Baumgartner, Christoph; Kletter, Kurt; Müller, Markus; Langer, Oliver // BMC Pharmacology;2007 Supplement 2, Vol. 7, Special section p1 

    Introduction (R)-[11C]Verapamil (VPM) is a new positron emission tomography (PET) tracer to measure P-glycoprotein (Pgp)-mediated transport at the blood-brain barrier (BBB). Owing to the lack of a suitable reference region in brain that is devoid of P-gp, a metabolite-corrected arterial input...

  • PI-35. Wang, J. S.; Zhu, H. J.; Gibson, B. B.; Donovan, J. L.; Markowitz, J. S.; DeVane, L. C. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP16 

    Background: The ABCB1 drug transporter P-glycoprotein (P-gp) plays an important function in the blood-brain barrier limiting a broad spectrum of substrates from entering the central nervous system. In the present study, the transport activity of P-gp for sertraline, bupropion, and their major...

  • Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins. Beck, W T; Grogan, T M // Leukemia (08876924);Jul97, Vol. 11 Issue 7, p1107 

    The problem of tumor cell drug resistance remains a barrier to the successful treatment of many neoplastic diseases. Problems of tumor cell heterogeneity and expression of multiple mechanisms of drug resistance complicate treatment strategies. Indeed, even that form of resistance to natural...

  • P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors. Schneider, Jose; Rubio, Mari-Paz // JNCI: Journal of the National Cancer Institute;6/1/94, Vol. 86 Issue 11, p850 

    Focuses on the role of P-glycoprotein in multidrug resistance to chemotherapy in gynecologic cancer. Overexpression of P-glycoprotein and worsening of prognosis; Mammary carcinomas; Endometrial and cervical carcinomas.

  • Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia. van der Kolk, D M; de Vries, E G E; Noordhoek, L; van den Berg, E; van der Pol, M A; M�ller, M; Vellenga, E // Leukemia (08876924);Oct2001, Vol. 15 Issue 10, p1544 

    The multidrug resistance proteins (MRPs) MRP1, MRP2, MRP3, MRP5 and P-glycoprotein (P-gp) act in concert with each other to give a net resultant pump function in acute myeloid leukemia (AML). The aim of the present study was to analyze the activity of these proteins, which might be upregulated...

  • Preface. Kozikowski, Alan P.; Baraldi, Pier G. // Current Pharmaceutical Design;Feb2000, Vol. 6 Issue 3, p1l 

    Introduces articles about treatments and cures for cancer published in the February 2000 issue of the periodical 'Current Pharmaceutical Design.' Role of p-glycoprotein in chemotherapeutic drug resistance; Importance of oxidative stress and electron transfer in the mechanism of action of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics